Ireland
--:--IST
Recruiting Not applicable

The Construction and Clinical Application of an Integrated Perioperative Management System for Lung Cancer Based on Wearable Devices and Intelligent Platforms

NCT07310056 · tracked via the Priya Life Science China tracker
Phase
Not applicable
Started
2026-01-01
Last updated
2026-09-09

Condition(s) studied

Non-Small Cell Lung Cancer (NSCLC)RehabilitationThoracic SurgeryPerioperative Management

Investigational drug(s) / intervention(s)

Wearable-Based Digital Perioperative Rehabilitation SystemStandard Perioperative Rehabilitation Guidance

Wearable-Based Digital Perioperative Rehabilitation System: This intervention consists of a wearable-based digital perioperative rehabilitation system designed for patients with non-small cell lung cancer undergoing thoracic surgery. The system integrates continuous physiological monitoring, functional assessment, and remote rehabilitation management. During the preoperative phase, patients receive personalized prehabilitation including aerobic exercise, respiratory muscle training, and resistance training. Wearable devices continuously monitor heart rate, oxygen saturation, activity level, and walking distance, including real-time monitoring during the six-minute walk test. Portable pulmonary function testing and functional MRI (PREFUL) are used for baseline assessment. During the postoperative phase, patients receive 30 days of home-based digital rehabilitation, including daily exercise tasks, real-time data upload, electronic patient-reported outcomes, and remote feedback from clinicians via a digital platform. Rehabilitation plans are dynam

Standard Perioperative Rehabilitation Guidance: This behavioral intervention consists of standard perioperative rehabilitation guidance provided to patients undergoing thoracic surgery for non-small cell lung cancer. Patients receive routine preoperative assessment, standardized postoperative discharge education, and conventional rehabilitation instructions including breathing exercises, early mobilization, pain management, and activity recommendations. No structured prehabilitation program, wearable device monitoring, remote digital platform, or continuous physiological monitoring is provided. Post-discharge follow-up is conducted according to routine outpatient clinical practice.

Study summary

This study aims to develop and evaluate an integrated perioperative management system based on wearable devices and a digital rehabilitation platform for patients with non-small cell lung cancer (NSCLC) undergoing thoracic surgery. By combining preoperative functional assessment using the six-minute walk test (6MWT), continuous perioperative physiological monitoring, and structured postoperative home-based digital rehabilitation, this randomized controlled trial will investigate whether the wearable-based digital management model improves short-term postoperative pulmonary function, functional recovery, and clinical outcomes compared with standard perioperative care.

Eligibility

Sex
ALL
Min age
18 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: * Age ≥18 years and ≤85 years * Pathologically confirmed primary non-small cell lung cancer (NSCLC) * Scheduled to undergo elective curative-intent thoracoscopic lobectomy or segmentectomy * Able to independently operate a smartphone and wearable device, or able to do so with caregiver assistance * Willing to comply with study procedures and follow-up requirements * Provided written informed consent prior to participation Exclusion Criteria: * Preoperative long-term home oxygen therapy or severe resting respiratory failure * Presence of severe or uncontrolled cardiopulmonary disease, cerebrovascular disease, hepatic insufficiency, or renal insufficiency * Severe comorbid conditions that significantly limit physical activity or adherence to rehabilitation * Known or suspected allergy to materials used in wearable devices or medical adhesives * Any other condition that, in the judgment of the investigators, makes the participant unsuitable for study participation

Primary outcome measure(s)

  • Time from return to the ward to first postoperative ambulation — From return to the surgical ward to first postoperative out-of-bed ambulation, censored at the date of hospital discharge, assessed up to the date of initial discharge (typically up to 14 days post-surgery).
    Time, measured in hours, from the patient's return to the surgical ward after surgery to the first postoperative out-of-bed ambulation. First ambulation is defined as the patient getting out of bed and standing or walking, with or without assistance.

Trial sites (1)

FacilityCityRegionStatus
West China Hospital Chengdu China Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07310056 on ClinicalTrials.gov ↗ ← All trials in China